Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
Pfizer
Children's Hospital Medical Center, Cincinnati
Incyte Corporation
Ohio State University Comprehensive Cancer Center
CellCentric Ltd.
Daiichi Sankyo
Ohio State University Comprehensive Cancer Center
Boryung Pharmaceutical Co., Ltd
New York Medical College
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Bristol-Myers Squibb
Washington University School of Medicine
Kymera Therapeutics, Inc.
Ohio State University Comprehensive Cancer Center
Bio-Path Holdings, Inc.
Daiichi Sankyo
Kyowa Kirin Co., Ltd.
Pfizer
Wake Forest University Health Sciences
University Hospital Southampton NHS Foundation Trust
Stanford University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Stanford University
University of Nebraska
Ruijin Hospital
University of Nebraska
Therapeutic Advances in Childhood Leukemia Consortium
Eastern Cooperative Oncology Group
Asana BioSciences
Alexion Pharmaceuticals, Inc.
Karyopharm Therapeutics Inc
Columbia University
Mayo Clinic
National Institutes of Health Clinical Center (CC)
AbbVie
Aptevo Therapeutics
Fred Hutchinson Cancer Center
Huazhong University of Science and Technology
University of Michigan Rogel Cancer Center
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center